Search research articles
Contact Us
Filters
Showing results (61-70 of 311) with videos related to
Page
of 32
Sort By:
Current Atherosclerosis Reports
|
February 9, 2022
Transintestinal cholesterol excretion in health and disease
Damien Garçon, Jean-Matthieu Berger, Bertrand Cariou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 13, 2025
Versatile Functions of Hepatic Lipase in Lipoprotein Metabolism
Wieneke Dijk, Antoine Rimbert, Thibaud Sotin, et al.
Journal of Clinical Lipidology
|
August 6, 2025
Major lipoprotein(a) increase under IGF-1R inhibition in Graves' orbitopathy: A case report
Maxime Carpentier, Pierre-Olivier Bertho, Pierre Lebranchu, et al.
Clinical Therapeutics
|
August 18, 2015
Patient and Physician Perspectives on Mode of Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels
Eli M Roth, Maja Bujas-Bobanovic, Michael J Louie, et al.
JAMA Cardiology
|
November 4, 2020
Genetic Inhibition of PCSK9 and Liver Function
Antoine Rimbert, Sarra Smati, Wieneke Dijk, et al.
Archives of Cardiovascular Diseases
|
December 19, 2022
Lipid-lowering efficacy and safety of alirocumab in a real-life setting in France: Insights from the ODYSSEY APPRISE study
Patrick Henry, Bertrand Cariou, Michel Farnier, et al.
Annales D'Endocrinologie
|
June 14, 2024
Exogenous Cushing's syndrome secondary to the use of depigmenting dermatocorticosteroids
Bazoumana Coulibaly, Sarra Smati-Grangeon, Bertrand Cariou, et al.
International Journal of Cardiology
|
August 31, 2016
Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials
Michel Farnier, Daniel Gaudet, Velichka Valcheva, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 27, 2019
Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials
Cyrus DeSouza, Bertrand Cariou, Satish Garg, et al.
Annales D'Endocrinologie
|
February 22, 2020
Improvement in arterial stiffness (pOpmètre®) after bariatric surgery. Results from a prospective study
Samuel Frey, David Jacobi, Matthieu Pichelin, et al.
Page
of 32
Search research articles
Search
Showing results (61-70 of 311) with videos related to
Sort By:
Page
of 32
Current Atherosclerosis Reports
|
February 9, 2022
Transintestinal cholesterol excretion in health and disease
Damien Garçon, Jean-Matthieu Berger, Bertrand Cariou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 13, 2025
Versatile Functions of Hepatic Lipase in Lipoprotein Metabolism
Wieneke Dijk, Antoine Rimbert, Thibaud Sotin, et al.
Journal of Clinical Lipidology
|
August 6, 2025
Major lipoprotein(a) increase under IGF-1R inhibition in Graves' orbitopathy: A case report
Maxime Carpentier, Pierre-Olivier Bertho, Pierre Lebranchu, et al.
Clinical Therapeutics
|
August 18, 2015
Patient and Physician Perspectives on Mode of Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels
Eli M Roth, Maja Bujas-Bobanovic, Michael J Louie, et al.
JAMA Cardiology
|
November 4, 2020
Genetic Inhibition of PCSK9 and Liver Function
Antoine Rimbert, Sarra Smati, Wieneke Dijk, et al.
Archives of Cardiovascular Diseases
|
December 19, 2022
Lipid-lowering efficacy and safety of alirocumab in a real-life setting in France: Insights from the ODYSSEY APPRISE study
Patrick Henry, Bertrand Cariou, Michel Farnier, et al.
Annales D'Endocrinologie
|
June 14, 2024
Exogenous Cushing's syndrome secondary to the use of depigmenting dermatocorticosteroids
Bazoumana Coulibaly, Sarra Smati-Grangeon, Bertrand Cariou, et al.
International Journal of Cardiology
|
August 31, 2016
Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials
Michel Farnier, Daniel Gaudet, Velichka Valcheva, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 27, 2019
Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials
Cyrus DeSouza, Bertrand Cariou, Satish Garg, et al.
Annales D'Endocrinologie
|
February 22, 2020
Improvement in arterial stiffness (pOpmètre®) after bariatric surgery. Results from a prospective study
Samuel Frey, David Jacobi, Matthieu Pichelin, et al.
Page
of 32